Trial intelligence / Profile preview

Intraperitoneal ketamine for post-cesarean pain

IRCT20251029067816N1Phase 3Completed

Sponsor
Alborz University of Medical Sciences
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ketamine in postoperative pain (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Pain intensity and Recovery complications after cesarean. Started Dec 2025; status: completed.

02

Drugs

ketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20251029067816N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20251029067816N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call